Incb28060
| Title | Journal |
|---|---|
| The novel c-Met inhibitor capmatinib mitigates diethylnitrosamine acute liver injury in mice. | Toxicology letters 20161102 |
| A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3. | Clinical cancer research : an official journal of the American Association for Cancer Research 20111115 |